BCL2 and hematologic disorder: The therapeutic potential of targeting anti-apoptotics like BCL2 and MCL1 in hematologic malignancies is extensively reviewed in (140) and we have reported on the intersection of cellular metabolism and BCL-2 proteins in (127).